Emil Kakkis is a medical geneticist and the founder, president, and CEO of Ultragenyx, a biopharmaceutical company focused on developing treatments for rare.
Emil Kakkis is a medical geneticist and the founder, president, and CEO of Ultragenyx, a biopharmaceutical company focused on developing treatments for rare and ultra-rare genetic diseases. He led Ultragenyx to become a public company with a market value of $2.6 billion, traded on the Nasdaq under the symbol RARE. Kakkis is known for his work in treating ultra-rare disorders through innovative therapeutic approaches.
Full founder directory · Investor directory · Company funding database · Fundraising library